The Translational Core is designed to meet the needs of clinical, basic, and population scientists who require the analysis of human tumors for their research. This need has been made manifest by a large increase in the utilization of tissue sectioning and analysis services by Cancer Center members. Indeed, the ability to gain access to and study human tumor tissue was rated as of """"""""highest priority"""""""" for expanded development in the Cancer Center strategic plan. The Core will provide immunohistochemistry (IHC), immunofluorescence (IF), and fluorescence in situ hybridization (FISH) assays for frozen and paraffin embedded tissues, design and histologically confirm tissue micro-arrays from paraffin blocks, characterize and validate monoclonal and polyclonal antibodies for use on tissue sections, and carry out somatic mutational analysis of DNA. The Core will be co-led by Drs. Lynn Dressier, a leader in the use of tissue analysis in translational research, and Leigh Thome, a Pathologist certified in Molecular Pathology. The Core adds value by providing a centralized resource--expertise, quality controlled, assured and validated procedures, state-of-the-art equipment, histopathologic evaluation, and access to human specimens- to perform and interpret morphology-based assays and somatic DNA mutation analysis. Access to and utilization of this core facility will promote the translation of basic science findings to human cancers and allow clinical investigators to perform innovative clinical trials using molecular correlates and endpoints. It will serve population scientists with large numbers of samples requiring morphologic or tissue-based assays. It will also serve as an essential component for molecular epidemiology studies. Future plans include the acquisition of additional equipment for automation and the development of RNA extraction techniques from paraffin blocks.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016086-32
Application #
7426409
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2006-12-01
Budget End
2007-11-30
Support Year
32
Fiscal Year
2007
Total Cost
$303,163
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Che, Tao; Majumdar, Susruta; Zaidi, Saheem A et al. (2018) Structure of the Nanobody-Stabilized Active State of the Kappa Opioid Receptor. Cell 172:55-67.e15
Hu, Peirong; Bi, Yanmin; Ma, Hong et al. (2018) Superior lentiviral vectors designed for BSL-0 environment abolish vector mobilization. Gene Ther 25:454-472
Townsley, Loni; Yannarell, Sarah M; Huynh, Tuanh Ngoc et al. (2018) Cyclic di-AMP Acts as an Extracellular Signal That Impacts Bacillus subtilis Biofilm Formation and Plant Attachment. MBio 9:
Schulfer, Anjelique F; Battaglia, Thomas; Alvarez, Yelina et al. (2018) Intergenerational transfer of antibiotic-perturbed microbiota enhances colitis in susceptible mice. Nat Microbiol 3:234-242
Hall, Marissa G; Mendel, Jennifer R; Noar, Seth M et al. (2018) Why smokers avoid cigarette pack risk messages: Two randomized clinical trials in the United States. Soc Sci Med 213:165-172
Cholon, Deborah M; Gentzsch, Martina (2018) Recent progress in translational cystic fibrosis research using precision medicine strategies. J Cyst Fibros 17:S52-S60
Tappata, Manaswita; Eluri, Swathi; Perjar, Irina et al. (2018) Association of mast cells with clinical, endoscopic, and histologic findings in adults with eosinophilic esophagitis. Allergy 73:2088-2092
Deng, Jiehui; Wang, Eric S; Jenkins, Russell W et al. (2018) CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation. Cancer Discov 8:216-233
Brenner, Alison T; Malo, Teri L; Margolis, Marjorie et al. (2018) Evaluating Shared Decision Making for Lung Cancer Screening. JAMA Intern Med 178:1311-1316
Cranston, Ross D; Cespedes, Michelle S; Paczuski, Pawel et al. (2018) High Baseline Anal Human Papillomavirus and Abnormal Anal Cytology in a Phase 3 Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Individuals Older Than 26 Years: ACTG 5298. Sex Transm Dis 45:266-271

Showing the most recent 10 out of 1525 publications